Evaluation of the keratinocytes or fibroblasts culture supernatant in an inflammatory hyperalgesia model

Detalhes bibliográficos
Autor(a) principal: Souza,Cíntia Ávila
Data de Publicação: 2020
Outros Autores: Santos,Gilson Gonçalves dos, Farias,Felipe Hertzing, Souza Júnior,Eli Ávila, Parada,Carlos Amilcar
Tipo de documento: Artigo
Idioma: eng
Título da fonte: BrJP (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2595-31922020000300199
Resumo: ABSTRACT BACKGROUND AND OBJECTIVES: Inflammation is a defense response of the body to a cellular damage caused by physical, chemical or biological agents, which triggers, among other factors, pain. Although inflammation plays an important role in the protection and regeneration of tissue injury, inflammatory pain results in decreased quality of life. In view of this, the development of safe and less invasive forms for the treatment of inflammatory pain is of great importance. The objective of this study was to evaluate the antihyperalgesic potential of the culture supernatant of keratinocytes and human fibroblasts in an experimental model of inflammatory hyperalgesia. METHODS: Evaluation of carrageenan induced inflammatory hyperalgesia through the use of electronic von Frey in animal models treated with culture supernatant of keratinocytes and fibroblasts. RESULTS: Local administration of naloxone, a nonselective opioid antagonist, in peripheral tissue, has been observed to inhibit the antihyperalgesic effect of the keratinocyte culture supernatant. Fibroblast culture supernatant on days 1 and 3 reverses for 2 hours the carrageenan induced inflammatory hyperalgesia, which is mediated by µ opioid agonist. CONCLUSION: This study indicates that culture supernatant of fibroblasts and keratinocytes is capable of inducing antinociception in inflammatory hyperalgesia, mediated by the release of endogenous opioids. In addition, it has been observed that the analgesic effect of the fibroblast culture supernatant is mediated specifically by the µ opioid agonist, having a duration of 2 hours.
id SBED-2_c78da61e52dd41774c020fa23d1d24ff
oai_identifier_str oai:scielo:S2595-31922020000300199
network_acronym_str SBED-2
network_name_str BrJP (Online)
repository_id_str
spelling Evaluation of the keratinocytes or fibroblasts culture supernatant in an inflammatory hyperalgesia modelAnalgesiaFibroblastsKeratinocytesPeripheral nervous systemSkinABSTRACT BACKGROUND AND OBJECTIVES: Inflammation is a defense response of the body to a cellular damage caused by physical, chemical or biological agents, which triggers, among other factors, pain. Although inflammation plays an important role in the protection and regeneration of tissue injury, inflammatory pain results in decreased quality of life. In view of this, the development of safe and less invasive forms for the treatment of inflammatory pain is of great importance. The objective of this study was to evaluate the antihyperalgesic potential of the culture supernatant of keratinocytes and human fibroblasts in an experimental model of inflammatory hyperalgesia. METHODS: Evaluation of carrageenan induced inflammatory hyperalgesia through the use of electronic von Frey in animal models treated with culture supernatant of keratinocytes and fibroblasts. RESULTS: Local administration of naloxone, a nonselective opioid antagonist, in peripheral tissue, has been observed to inhibit the antihyperalgesic effect of the keratinocyte culture supernatant. Fibroblast culture supernatant on days 1 and 3 reverses for 2 hours the carrageenan induced inflammatory hyperalgesia, which is mediated by µ opioid agonist. CONCLUSION: This study indicates that culture supernatant of fibroblasts and keratinocytes is capable of inducing antinociception in inflammatory hyperalgesia, mediated by the release of endogenous opioids. In addition, it has been observed that the analgesic effect of the fibroblast culture supernatant is mediated specifically by the µ opioid agonist, having a duration of 2 hours.Sociedade Brasileira para o Estudo da Dor2020-09-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S2595-31922020000300199BrJP v.3 n.3 2020reponame:BrJP (Online)instname:Sociedade Brasileira para o Estudo da Dor (SBED)instacron:SBED10.5935/2595-0118.20200038info:eu-repo/semantics/openAccessSouza,Cíntia ÁvilaSantos,Gilson Gonçalves dosFarias,Felipe HertzingSouza Júnior,Eli ÁvilaParada,Carlos Amilcareng2020-09-18T00:00:00Zoai:scielo:S2595-31922020000300199Revistahttps://sbed.org.br/publicacoes-publicacoes-bjp/ONGhttps://old.scielo.br/oai/scielo-oai.phpdkt@terra.com.br || dor@dor.org.br2595-31922595-0118opendoar:2020-09-18T00:00BrJP (Online) - Sociedade Brasileira para o Estudo da Dor (SBED)false
dc.title.none.fl_str_mv Evaluation of the keratinocytes or fibroblasts culture supernatant in an inflammatory hyperalgesia model
title Evaluation of the keratinocytes or fibroblasts culture supernatant in an inflammatory hyperalgesia model
spellingShingle Evaluation of the keratinocytes or fibroblasts culture supernatant in an inflammatory hyperalgesia model
Souza,Cíntia Ávila
Analgesia
Fibroblasts
Keratinocytes
Peripheral nervous system
Skin
title_short Evaluation of the keratinocytes or fibroblasts culture supernatant in an inflammatory hyperalgesia model
title_full Evaluation of the keratinocytes or fibroblasts culture supernatant in an inflammatory hyperalgesia model
title_fullStr Evaluation of the keratinocytes or fibroblasts culture supernatant in an inflammatory hyperalgesia model
title_full_unstemmed Evaluation of the keratinocytes or fibroblasts culture supernatant in an inflammatory hyperalgesia model
title_sort Evaluation of the keratinocytes or fibroblasts culture supernatant in an inflammatory hyperalgesia model
author Souza,Cíntia Ávila
author_facet Souza,Cíntia Ávila
Santos,Gilson Gonçalves dos
Farias,Felipe Hertzing
Souza Júnior,Eli Ávila
Parada,Carlos Amilcar
author_role author
author2 Santos,Gilson Gonçalves dos
Farias,Felipe Hertzing
Souza Júnior,Eli Ávila
Parada,Carlos Amilcar
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Souza,Cíntia Ávila
Santos,Gilson Gonçalves dos
Farias,Felipe Hertzing
Souza Júnior,Eli Ávila
Parada,Carlos Amilcar
dc.subject.por.fl_str_mv Analgesia
Fibroblasts
Keratinocytes
Peripheral nervous system
Skin
topic Analgesia
Fibroblasts
Keratinocytes
Peripheral nervous system
Skin
description ABSTRACT BACKGROUND AND OBJECTIVES: Inflammation is a defense response of the body to a cellular damage caused by physical, chemical or biological agents, which triggers, among other factors, pain. Although inflammation plays an important role in the protection and regeneration of tissue injury, inflammatory pain results in decreased quality of life. In view of this, the development of safe and less invasive forms for the treatment of inflammatory pain is of great importance. The objective of this study was to evaluate the antihyperalgesic potential of the culture supernatant of keratinocytes and human fibroblasts in an experimental model of inflammatory hyperalgesia. METHODS: Evaluation of carrageenan induced inflammatory hyperalgesia through the use of electronic von Frey in animal models treated with culture supernatant of keratinocytes and fibroblasts. RESULTS: Local administration of naloxone, a nonselective opioid antagonist, in peripheral tissue, has been observed to inhibit the antihyperalgesic effect of the keratinocyte culture supernatant. Fibroblast culture supernatant on days 1 and 3 reverses for 2 hours the carrageenan induced inflammatory hyperalgesia, which is mediated by µ opioid agonist. CONCLUSION: This study indicates that culture supernatant of fibroblasts and keratinocytes is capable of inducing antinociception in inflammatory hyperalgesia, mediated by the release of endogenous opioids. In addition, it has been observed that the analgesic effect of the fibroblast culture supernatant is mediated specifically by the µ opioid agonist, having a duration of 2 hours.
publishDate 2020
dc.date.none.fl_str_mv 2020-09-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2595-31922020000300199
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2595-31922020000300199
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.5935/2595-0118.20200038
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira para o Estudo da Dor
publisher.none.fl_str_mv Sociedade Brasileira para o Estudo da Dor
dc.source.none.fl_str_mv BrJP v.3 n.3 2020
reponame:BrJP (Online)
instname:Sociedade Brasileira para o Estudo da Dor (SBED)
instacron:SBED
instname_str Sociedade Brasileira para o Estudo da Dor (SBED)
instacron_str SBED
institution SBED
reponame_str BrJP (Online)
collection BrJP (Online)
repository.name.fl_str_mv BrJP (Online) - Sociedade Brasileira para o Estudo da Dor (SBED)
repository.mail.fl_str_mv dkt@terra.com.br || dor@dor.org.br
_version_ 1754732510321836032